-
FDA Explains How It Is Trying To Manage Drug Safety Issues
FDA’s Paul Seligman Answers Some Questions About The Agency’s Drug Oversight Performance (Posted by Tom Lamb at DrugInjuryWatch.com) Paul Seligman, M.D., M.P.H., is Associate Director of Safety Policy and Communication in FDA’s Center for…
-
Long-Awaited Natrecor Trial Starts To Enroll Patients In June 2007
Scios Inc. Finally Going To Assess Benefit / Risk Profile Of Natrecor In Large Trial Of Patients With Acutely Decompensated Heart Failure On June 8, 2007 Scios, Inc. let the public know that it…
-
900 More Zyprexa Lawsuits Settled By Eli Lilly And Co.
Drug Maker Still Faces Product Liability Cases Involving 750 Zyprexa Patients (Posted by Tom Lamb at DrugInjuryWatch.com) A June 12, 2007 Associated Press (AP) article reports that the Eli Lilly and Co. has settled…
-
Following FDA’s Action, Novartis’ Zelnorm Gets Recall Order From Chinese Drug Regulator
China’s State Food & Drug Administration Says Zelnorm Side Effect Risks Outweigh This Drug’s Benefits (Posted by Tom Lamb at DrugInjuryWatch.com) A June 8, 2007 Associated Press (AP) article published in The Washington Post…
-
Emerging Drug Safety Issue Regarding Abbott’s TriCor Triglycerides Medication
Barron’s June 2007 Report: Experts Are Concerned That TriCor May Cause Decline In Kidney Functions (Posted by Tom Lamb at DrugInjuryWatch.com) The weekly business newspaper Barron’s reported on June 3, 2007 that some expert…
-
Novartis Ordered To Recall Zelnorm From Market In Switzerland
Swiss Pharmaceutical Regulator States That Side Effect Risks Outweigh Benefits (Posted by Tom Lamb at DrugInjuryWatch.com) In a brief June 1, 2007 Wall Street Journal (WSJ) article it was reported that Switzerland’s pharmaceuticals regulator…